ID

28373

Beschreibung

This trial will enroll approximately 6,000 patients with recent embolic stroke of unknown source (ESUS). Patients will be randomized to dabigatran or acetylsalicyclic acid (ASA) (1:1 ratio) and have visits every three months. The study doctor may prescribe blinded concomitant ASA for pts with coronary artery disease but this is not mandatory. All Adverse Events (AEs), Serious Adverse Events (SAEs), outcome events will be recorded. The trial will conclude when the required number of stroke events are positively adjudicated which is estimated to take 3 years (including 2.5 years of enrollment). Sponsor / Information provided by (Responsible Party): Boehringer Ingelheim. https://clinicaltrials.gov/ct2/show/NCT02239120?term=NCT02239120&cond=NCT02239120&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT02239120?term=NCT02239120&cond=NCT02239120&rank=1

Stichworte

  1. 08.01.18 08.01.18 -
Rechteinhaber

Boehringer Ingelheim

Hochgeladen am

8. Januar 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility criteria RE-SPECT ESUS Embolic Stroke NCT02239120

Eligibility criteria RE-SPECT ESUS Embolic Stroke NCT02239120

Inclusion criteria
Beschreibung

Inclusion criteria

Ischemic stroke with a brain lesion visualized by neuroimaging (either brain Computed Tomography (CT) or Magnetic Resonance Image (MRI))
Beschreibung

The visualized stroke is a non-lacunar infarct , e.g. involving the cortex or >1.5 cm (>2.0 cm if measured on MRI diffusion-weighted images) in largest diameter if exclusively subcortical.Visualization by CT usually requires delayed imaging >24-48 hours after stroke onset.

Datentyp

boolean

The index stroke must have occurred either up to 3 months before randomization (Modified Rankin Scale(mRS) <=3 at randomization) or up to 6 months before randomization (mRS <=3 at randomization) in selected patients that are >= 60 years plus at least one additional risk factor for recurrent stroke
Beschreibung

stroke time of occurence

Datentyp

boolean

Arterial imaging or cervical plus TCD ultrasonography does not show extra-cranial or intracranial atherosclerosis with >= 50% luminal stenosis in artery supplying the area of acute ischemia
Beschreibung

atherosclerosis

Datentyp

boolean

As evidenced by cardiac monitoring for >= 20 hours with automated rhythm detection, there is absence of AF > 6 minutes in duration
Beschreibung

(within a 20 hour period, either as single episode or cumulative time of multiple episodes)

Datentyp

boolean

Exclusion criteria
Beschreibung

Exclusion criteria

Modified Rankin Scale of >=4 at time of randomization or inability to swallow medications
Beschreibung

Modified Rankin Scale

Datentyp

boolean

Major risk cardioembolic source of embolism .
Beschreibung

such as: a) intracardiac thrombus as evidenced by transthoracic or transesophageal echocardiography, b) paroxysmal, persistent or permanent AF, c) atrial flutter, d) prosthetic cardiac valve (mitral or aortic, bioprosthetic or mechanical), e) atrial myxoma, f) other cardiac tumors, g) moderate or severe mitral stenosis, h) recent (< 4weeks) myocardial infarction, i) valvular vegetations, or j) infective endocarditis

Datentyp

boolean

Any indication that requires treatment with an anticoagulant as per Investigator`s judgment
Beschreibung

anticoagulant

Datentyp

boolean

History of atrial fibrillation (unless it was due to reversible causes such as hyperthyroidism or binge drinking, and has been permanently resolved)
Beschreibung

History of atrial fibrillation

Datentyp

boolean

Other specific stroke etiology
Beschreibung

i.e. cerebral arteritis or arterial dissection, migraine with aura/vasospasm, drug abuse

Datentyp

boolean

Renal impairment
Beschreibung

Renal impairment with estimated creatinine clearance (as calculated by Cockcroft-Gault equation) <30mL/min at screening, or where Investigator expects creatinine clearance is likely to drop below 30mL/min during the course of the study

Datentyp

boolean

Ähnliche Modelle

Eligibility criteria RE-SPECT ESUS Embolic Stroke NCT02239120

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion criteria
Ischemic stroke
Item
Ischemic stroke with a brain lesion visualized by neuroimaging (either brain Computed Tomography (CT) or Magnetic Resonance Image (MRI))
boolean
stroke time of occurence
Item
The index stroke must have occurred either up to 3 months before randomization (Modified Rankin Scale(mRS) <=3 at randomization) or up to 6 months before randomization (mRS <=3 at randomization) in selected patients that are >= 60 years plus at least one additional risk factor for recurrent stroke
boolean
atherosclerosis
Item
Arterial imaging or cervical plus TCD ultrasonography does not show extra-cranial or intracranial atherosclerosis with >= 50% luminal stenosis in artery supplying the area of acute ischemia
boolean
absence of atrial fibrillation
Item
As evidenced by cardiac monitoring for >= 20 hours with automated rhythm detection, there is absence of AF > 6 minutes in duration
boolean
Item Group
Exclusion criteria
Modified Rankin Scale
Item
Modified Rankin Scale of >=4 at time of randomization or inability to swallow medications
boolean
embolism
Item
Major risk cardioembolic source of embolism .
boolean
anticoagulant
Item
Any indication that requires treatment with an anticoagulant as per Investigator`s judgment
boolean
History of atrial fibrillation
Item
History of atrial fibrillation (unless it was due to reversible causes such as hyperthyroidism or binge drinking, and has been permanently resolved)
boolean
Other specific stroke etiology
Item
Other specific stroke etiology
boolean
Renal impairment
Item
Renal impairment
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video